Lifevantage Corporation (LFVN) To Go Ex-Dividend on June 1st

Lifevantage Corporation (NASDAQ:LFVN) announced a quarterly dividend on Monday, April 27th. Investors of record on Monday, June 1st will be given a dividend of 0.05 per share on Monday, June 15th. This represents a c) annualized dividend and a dividend yield of 2.5%. The ex-dividend date of this dividend is Monday, June 1st. This is a 11.1% increase from Lifevantage’s previous quarterly dividend of $0.05.

Lifevantage has a payout ratio of 18.5% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Lifevantage to earn $0.65 per share next year, which means the company should continue to be able to cover its $0.20 annual dividend with an expected future payout ratio of 30.8%.

Lifevantage Stock Up 3.0%

NASDAQ LFVN opened at $7.90 on Friday. Lifevantage has a twelve month low of $3.90 and a twelve month high of $15.00. The firm has a market capitalization of $99.70 million, a PE ratio of 17.56 and a beta of 0.52. The stock’s 50 day moving average is $5.03 and its 200 day moving average is $5.56.

Lifevantage (NASDAQ:LFVN) last released its quarterly earnings results on Wednesday, May 6th. The company reported $0.12 earnings per share for the quarter, missing the consensus estimate of $0.16 by ($0.04). Lifevantage had a net margin of 2.94% and a return on equity of 23.89%. The firm had revenue of $43.72 million for the quarter, compared to the consensus estimate of $47.77 million. On average, research analysts anticipate that Lifevantage will post 0.6 earnings per share for the current year.

Insider Activity at Lifevantage

In other Lifevantage news, Director Judd Dayton acquired 10,500 shares of the company’s stock in a transaction that occurred on Monday, March 2nd. The shares were bought at an average cost of $4.53 per share, with a total value of $47,565.00. Following the completion of the transaction, the director directly owned 80,359 shares of the company’s stock, valued at approximately $364,026.27. This represents a 15.03% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 21.95% of the stock is owned by company insiders.

Institutional Investors Weigh In On Lifevantage

Institutional investors have recently modified their holdings of the business. Capital Management Corp VA boosted its position in shares of Lifevantage by 63.0% during the third quarter. Capital Management Corp VA now owns 2,064,176 shares of the company’s stock valued at $20,084,000 after buying an additional 798,066 shares during the last quarter. JPMorgan Chase & Co. boosted its position in shares of Lifevantage by 870.2% during the second quarter. JPMorgan Chase & Co. now owns 5,016 shares of the company’s stock valued at $66,000 after buying an additional 4,499 shares during the last quarter. Bank of America Corp DE boosted its position in shares of Lifevantage by 24.3% during the first quarter. Bank of America Corp DE now owns 23,445 shares of the company’s stock valued at $101,000 after buying an additional 4,586 shares during the last quarter. Bank of New York Mellon Corp boosted its position in shares of Lifevantage by 11.9% during the first quarter. Bank of New York Mellon Corp now owns 33,547 shares of the company’s stock valued at $145,000 after buying an additional 3,571 shares during the last quarter. Finally, Hsbc Holdings PLC purchased a new stake in shares of Lifevantage during the first quarter valued at $51,000. 35.32% of the stock is owned by hedge funds and other institutional investors.

About Lifevantage

LifeVantage Corporation is a publicly traded company that develops, markets and distributes nutritional supplements, skincare products and weight-management solutions through a direct-selling business model. The company’s flagship offering, Protandim®, is formulated to activate the Nrf2 pathway, which is associated with cellular defense processes. LifeVantage also markets the PhysIQ® line for metabolism and body composition support and the TrueScience® skincare regimen, targeting a range of health and wellness needs.

Founded in 1999 and headquartered in Sandy, Utah, LifeVantage combines research in nutrigenomics with a network of independent distributors to bring its products to market.